EXETER – Vapotherm has ramped up production of its innovative device used in the respiratory treatment of hospitalized COVID-19 patients “20-fold,” according to CEO Joe Army.
The Vapotherm technology – known as the Precision Flow Hi-VNI system – is regarded by the company as a safer alternative to the ventilators used by hospitals for critically ill COVID patients.
While use of a ventilator requires intubation (inserting a tube, called an endotracheal tube, through the mouth and then into the airway so that a patient can be placed on a ventilator), Vapotherm’s device uses what is called a “high-flow nasal cannula.”
Instead of down the throat, this method attaches a cannula (soft plastic fitted prongs) onto the nose for high-volume delivery of properly humidified air into the body of a patient suffering from a respiratory ailment such as COVID-19.
“We’re a specialized form of high flow nasal cannula, and we’re actually